weight / management
LOT / AX-K-20
§ Product monograph
RETAKLIK 20mg
20mg · single-vial research unit
Triple-agonist metabolic pen supporting appetite control, glucose regulation and energy expenditure.
Active
Retatrutide
Dosage / vial
20mg
Purity
99.071%
Batch
001/26
£189.00
per vial · excl. shipping
Mechanism
Tirzepatide-class dual incretin agonist modulating glucose homeostasis and appetite signalling via GIP and GLP-1 pathways.
Metabolic enhancement
Weight support
Better glucose control
1
For research use only. Not for human consumption. Analytical report on file.
§ Referenced studies
The evidence
Study index is being updated. Contact us for a full research bibliography for RETAKLIK 20mg.